APR 23, 2018 12:37 PM PDT

Damaged Heart Cells Can Regenerate Using Innovative Technique

WRITTEN BY: Kara Marker

There is no definitive “treatment” for the damage that results from a heart attack because the heart cells cannot regenerate themselves after such an attack. But scientists from Columbia University present a new approach that involves using heart cells’ own molecular messages to improve regeneration after a heart attack.

Immunofluorescent staining for F-actin filaments (green) and nuclei (blue) in neonatal cardiomyocytes. Credit: Ps1415

After the death of heart muscle cells, called cardiomyocytes, in the wake of a heart attack, the heart is unable to adequately pump blood. Essentially, the heart is forced to do the same job but with less cells.

The response by scientists from all over the world has recently been stem cell transplantation to replace dead and damaged cardiomyocytes with new cells to improve heart function after a heart attack. However, there are several problems associated with this approach. First, implanted stem cells don’t always survive or successfully transform into cardiomyocytes as intended. Additionally, implanted cardiomyocytes often fail to beat synchronously with the heart, increasing the risk of dangerous abnormal heart rhythms called arrhythmias.

The new approach designed by the team from Columbia University involves applying extracellular vesicles secreted by the cardiomyocytes themselves. These vesicles are secreted by virtually all cell types, and cells use the genetic information the vesicles contain to communicate with other cells.

“We postulated that the benefits of cell therapy of the heart could be coming from the secreted bioactive molecules (such as microRNAs), rather than the cells themselves," explained senior author Vunjak-Novakovic. "So we explored whether the benefits of cell therapy of the injured heart could be achieved without using the cells. This way, we would largely simplify the translation into the clinic, and avoid the burden of arrhythmia associated with implantation of contractile cells."

Developing a therapeutic approach to heart attack using these vesicles has several advantages over a more traditional cell-based therapy. First, the vesicles are easily to isolate and store, so they can either be used immediately in an “acute-care setting” or be saved for later use. As opposed to implanted stem cells, extracellular vesicles do not raise the risk of arrhythmia, and their regulatory path towards clinical application is simpler than the path for cell-based therapies.

Researchers evaluated the effectiveness of this approach first by isolated cardiomyocytes from adult human stem cells and collected their secreted extracellular vesicles. Next, they used next-generation sequencing to compare the genetic information in these vesicles compared to vesicles secreted by undifferentiated stem cells.

They found that extracellular vesicles from cardiomyocytes, not from undifferentiated stem cells, contained powerful regulatory molecules called “cardiogenic and vasculogenic microRNAs.”

Next researchers developed a collagen-based patch that takes the vesicles and releases them slowly over four weeks. They implanted the patch into the hearts of rats used as a model of heart attack. Researchers found that the rate of arrhythmia was much lower in this scenario than with cell therapy.

“By four weeks after treatment, the hearts treated with extracellular vesicles had similar cardiac function as those that were never injured,” Vunjak-Novakovic said.

"Once we better understand how exactly the extracellular vesicles do what they do," Vunjak-Novakovic concluded, "we should be able to extend their use to a range of cardiovascular diseases, and significantly advance the field of cell-free heart therapy."

The present study was published in the journal Nature Biomedical Engineering.

Source: Columbia University School of Engineering and Applied Science

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 05, 2018
Cardiology
DEC 05, 2018
Top 5 Medical Tests to Predict Heart Disease
  A group of five simple medical tests provides doctors and patients a long-term, wide-range glimpse into a person’s risk of developing heart di...
JUL 17, 2018
Cardiology
JUL 17, 2018
Heart Failure Death Rates Higher in Females than Males
Study shows that heart failure death rates and hospitalizations are higher in women then men, based on 900,000 cases studied in Ontario Canada....
SEP 03, 2018
Cardiology
SEP 03, 2018
Even the Fittest Can't Outrun Cardiovascular Disease
Master athletes can't outrun the risk of cardiovascular disease, increased risk of cardiovascular disease can still occur despite regular high-level exercise....
SEP 05, 2018
Cardiology
SEP 05, 2018
Higher Risk of Hypertension Associated with IVF Births
Individuals born via in vitro fertilization have increased blood pressure at an early age leading to higher risk of hypertension....
OCT 31, 2018
Health & Medicine
OCT 31, 2018
Childhood Obesity Raises Risk of Severe Hip Malformation
Obesity, especially in childhood can create a myriad of health issues that can persist into adulthood. Cardiovascular disease, strokes, hypertension and ev...
NOV 01, 2018
Neuroscience
NOV 01, 2018
How baroreceptors do blood pressure sensing
mechanical changes in the blood vessels is communicated to brain via mechanosensitive Piezo ion channels...
Loading Comments...